CEL-SCI Corporation (CVM)
Add to Watchlists Create an AlertCEL-SCI Corporation Enterprise Value:
68.43M for May 22, 2013CEL-SCI Corporation Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 22, 2013 | 68.43M |
| May 21, 2013 | 69.05M |
| May 20, 2013 | 66.88M |
| May 17, 2013 | 69.66M |
| May 16, 2013 | 70.59M |
| May 15, 2013 | 72.70M |
| May 14, 2013 | 72.70M |
| May 13, 2013 | 72.45M |
| May 10, 2013 | 72.76M |
| May 9, 2013 | 74.43M |
| May 8, 2013 | 72.94M |
| May 7, 2013 | 73.38M |
| May 6, 2013 | 75.97M |
| May 3, 2013 | 74.92M |
| May 2, 2013 | 71.21M |
| May 1, 2013 | 69.66M |
| April 30, 2013 | 72.76M |
| April 29, 2013 | 75.08M |
| April 26, 2013 | 74.77M |
| April 25, 2013 | 80.49M |
| April 24, 2013 | 76.87M |
| April 23, 2013 | 70.99M |
| April 22, 2013 | 72.14M |
| April 19, 2013 | 71.21M |
| April 18, 2013 | 70.28M |
| April 17, 2013 | 72.29M |
| April 16, 2013 | 75.60M |
| April 15, 2013 | 72.14M |
| April 12, 2013 | 71.24M |
| April 11, 2013 | 69.66M |
| April 10, 2013 | 71.21M |
| April 9, 2013 | 69.20M |
| April 8, 2013 | 72.76M |
| April 5, 2013 | 74.33M |
| April 4, 2013 | 74.77M |
| April 3, 2013 | 66.54M |
| April 2, 2013 | 67.35M |
| April 1, 2013 | 62.09M |
| March 28, 2013 | 60.48M |
| March 27, 2013 | 60.26M |
| March 26, 2013 | 55.69M |
| March 25, 2013 | 65.27M |
| March 22, 2013 | 67.71M |
| March 21, 2013 | 66.57M |
| March 20, 2013 | 66.50M |
| March 19, 2013 | 66.50M |
| March 18, 2013 | 66.50M |
| March 15, 2013 | 69.25M |
| March 14, 2013 | 67.34M |
| March 13, 2013 | 68.73M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
CVM Enterprise Value Benchmarks
| Companies | |
|---|---|
| ImmunoCellular Therapeutics | 106.07M |
| Sarepta Therapeutics | 970.21M |
| Biocryst Pharmaceuticals | 87.29M |
CVM Enterprise Value Rankings
| Overall |
52nd percentile 3820 of 8006 |
| Sector |
38th percentile 423 of 686 in Healthcare |
| Industry |
40th percentile 147 of 248 in Biotechnology |
CVM Enterprise Value Range, Past 5 Years
| Minimum | 18.59M | Feb 19 2009 |
| Maximum | 309.58M | Oct 1 2009 |
| Average | 90.11M |
